Qube Research & Technologies LTD Adma Biologics, Inc. Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 308,082 shares of ADMA stock, worth $5.68 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

308,082

Previous 416,421 26.02%

Holding current value

$5.68 Million

Previous $4.66 Million 32.29%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$11.21 - $20.03 $1.21 Million - $2.17 Million	-108,339 Reduced 26.02%	308,082 $6.16 Million
Q2 2024 Aug 14, 2024	BUY	$5.98 - $11.18 $1.36 Million - $2.55 Million	228,077 Added 121.1%	416,421 $4.66 Million
Q1 2024 May 14, 2024	SELL	$4.4 - $6.74 $2.57 Million - $3.93 Million	-583,127 Reduced 75.59%	188,344 $1.24 Million
Q4 2023 Feb 13, 2024	SELL	$3.08 - $4.52 $1.33 Million - $1.96 Million	-433,177 Reduced 35.96%	771,471 $3.49 Million
Q3 2023 Nov 13, 2023	BUY	$3.47 - $4.61 $779,695 - $1.04 Million	224,696 Added 22.93%	1,204,648 $4.31 Million
Q2 2023 Aug 14, 2023	BUY	$3.12 - $4.22 $1.39 Million - $1.88 Million	444,455 Added 83.0%	979,952 $3.62 Million
Q1 2023 May 15, 2023	BUY	$3.01 - $3.87 $1.49 Million - $1.91 Million	493,424 Added 1172.78%	535,497 $1.77 Million
Q4 2022 Feb 14, 2023	SELL	$2.47 - $3.88 $619,698 - $973,453	-250,890 Reduced 85.64%	42,073 $163,000
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $594,714 - $837,874	292,963 New	292,963 $712,000
Q2 2022 Aug 15, 2022	SELL	$1.43 - $2.2 $211,754 - $325,776	-148,080 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$1.28 - $1.83 $55,705 - $79,641	43,520 Added 41.62%	148,080 $271,000
Q4 2021 Feb 01, 2022	BUY	$1.09 - $1.66 $101,122 - $154,003	92,773 Added 787.08%	104,560 $147,000
Q3 2021 Nov 12, 2021	SELL	$1.13 - $1.65 $136,504 - $199,320	-120,800 Reduced 91.11%	11,787 $13,000
Q2 2021 Aug 13, 2021	BUY	$1.51 - $2.07 $145,559 - $199,541	96,397 Added 266.36%	132,587 $212,000
Q1 2021 May 14, 2021	BUY	$1.67 - $2.95 $60,437 - $106,760	36,190 New	36,190 $64,000
Q3 2020 Nov 12, 2020	SELL	$2.04 - $3.74 $72,560 - $133,028	-35,569 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.42 - $3.29 $86,076 - $117,022	35,569 New	35,569 $104,000

Others Institutions Holding ADMA

# of Institutions

318

Shares Held

184M

Call Options Held

917K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.62B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Adma Biologics, Inc. Transaction History